Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabidiol protects against Alzheimer's disease in C. elegans via ROS scavenging activity of its phenolic hydroxyl groups
Yue Zhang, Hongyuan Li, Sha Jin, et al.
European Journal of Pharmacology (2022) Vol. 919, pp. 174829-174829
Closed Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Modulation of Oxidative Stress and Neuroinflammation by Cannabidiol (CBD): Promising Targets for the Treatment of Alzheimer’s Disease
Jordan P. Hickey, Andrila E. Collins, Mackayla L. Nelson, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 5, pp. 4379-4402
Open Access | Times Cited: 9
Cannabinoids in the Modulation of Oxidative Signaling
Cristina Pagano, Beatrice Savarese, Laura Coppola, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2513-2513
Open Access | Times Cited: 22
Effects of Vegetal Extracts and Metabolites against Oxidative Stress and Associated Diseases: Studies in Caenorhabditis elegans
Estefani Yaquelin Hernández‐Cruz, Dianelena Eugenio-Pérez, Karla Jaqueline Ramírez-Magaña, et al.
ACS Omega (2023) Vol. 8, Iss. 10, pp. 8936-8959
Open Access | Times Cited: 18
Macrophage Membrane‐Modified MoS2 Quantum Dots as a Nanodrug for Combined Multi‐Targeting of Alzheimer's Disease
Xiating Qi, Lianxin Li, Pengkun Ye, et al.
Advanced Healthcare Materials (2023) Vol. 13, Iss. 6
Closed Access | Times Cited: 18
The pharmacology and therapeutic role of cannabidiol in diabetes
Jin Sheng Zhang, Cong Lin, Sha Jin, et al.
Exploration (2023) Vol. 3, Iss. 5
Open Access | Times Cited: 17
Caenorhabditis elegans: A transgenic model for studying age-associated neurodegenerative diseases
Nisha Rani, Mohammad Mumtaz Alam, Azfar Jamal, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102036-102036
Closed Access | Times Cited: 17
A multi-target directed ligands strategy for the treatment of Alzheimer's disease: Dimethyl fumarate plus Tranilast modified Dithiocarbate as AChE inhibitor and Nrf2 activator
Jie Guo, Maojun Cheng, Peng Liu, et al.
European Journal of Medicinal Chemistry (2022) Vol. 242, pp. 114630-114630
Closed Access | Times Cited: 21
Evaluation of phytochemical composition and metabolite profiling of macroalgae Caulerpa taxifolia and C. peltata from the Banda Aceh coast, Indonesia
Said Ali Akbar, MUHAMMAD HASAN, Sari Afriani, et al.
Biodiversitas Journal of Biological Diversity (2023) Vol. 24, Iss. 10
Open Access | Times Cited: 12
Vitamin B12 Ameliorates the Pathological Phenotypes of Multiple Parkinson’s Disease Models by Alleviating Oxidative Stress
Yue Wu, Zhongting Zhao, Naidi Yang, et al.
Antioxidants (2023) Vol. 12, Iss. 1, pp. 153-153
Open Access | Times Cited: 11
Cannabidiol Analogue CIAC001 for the Treatment of Morphine-Induced Addiction by Targeting PKM2
Sha Jin, Cong Lin, Yibo Wang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 16, pp. 11498-11516
Closed Access | Times Cited: 11
Therapeutic considerations of bioactive compounds in Alzheimer's disease and Parkinson's disease: Dissecting the molecular pathways
Banashree Chetia Phukan, Rubina Roy, Indira Gahatraj, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 12, pp. 5657-5699
Open Access | Times Cited: 11
Repurposing Drugs: A Promising Therapeutic Approach against Alzheimer’s Disease
Swagata Pattanaik, Aruna Ghose, Kakarla Pakeeraiah, et al.
Ageing Research Reviews (2025), pp. 102698-102698
Closed Access
Design and synthesis of butyrolactone V derivatives and its anti-inflammatory activity analysis
Wen Liu, Biqiong Zhang, Zhengxi Hu, et al.
Chinese Herbal Medicines (2025)
Open Access
Cannabidiol reverses myeloperoxidase hyperactivity in the prefrontal cortex and striatum, and reduces protein carbonyls in the hippocampus in a ketamine-induced schizophrenia rat model
Sofia de Almeida Queiroz, Linério Ribeiro de Novais Júnior, ANITA PACHECO, et al.
Schizophrenia Research (2025) Vol. 278, pp. 82-95
Closed Access
Investigation in the CB1 and CB2 receptor binding profile and intrinsic activity of (-) and (+)-enantiomers of some naturally occurring phytocannabinoids or synthetic derivatives
Santiago Rodríguez-Carreiro, María Gómez‐Cañas, Francesca Lubrini, et al.
European Journal of Medicinal Chemistry Reports (2025), pp. 100262-100262
Open Access
Mitigating Cannabidiol’s Non-Selective Cytotoxicity via Subcellular Organelle Targeting: Exploring Mitochondrial Targeting Potential
Guozhen Liu, Ru Li, Jingwei Gao, et al.
Bioconjugate Chemistry (2025)
Closed Access
Amyloid β-but not Tau-induced neurotoxicity is suppressed by Manuka honeyviaHSP-16.2 and SKN-1/Nrf2 pathways in anin vivomodel of Alzheimer's disease
María D. Navarro‐Hortal, José M. Romero‐Márquez, Pedro Muñoz-Ollero, et al.
Food & Function (2022) Vol. 13, Iss. 21, pp. 11185-11199
Open Access | Times Cited: 17
The role of cannabidiol in aging
Beibei Ni, Yanying Liu, Meng Dai, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115074-115074
Open Access | Times Cited: 10
Oral lipid-based formulations alter delivery of cannabidiol to different anatomical regions in the brain
Alice Brookes, Adelaide Jewell, Wanshan Feng, et al.
International Journal of Pharmaceutics (2023) Vol. 635, pp. 122651-122651
Open Access | Times Cited: 9
Involvement of CKS1B in the anti-inflammatory effects of cannabidiol in experimental stroke models
Kechun Chen, Bingtian Xu, Xuan Xiao, et al.
Experimental Neurology (2023) Vol. 373, pp. 114654-114654
Closed Access | Times Cited: 8
Cannabidiol (CBD) Supports the Honeybee Worker Organism by Activating the Antioxidant System
Patrycja Skowronek, Aneta Strachecka
Antioxidants (2023) Vol. 12, Iss. 2, pp. 279-279
Open Access | Times Cited: 7
Protective effects of lignin fractions obtained from grape seeds against bisphenol AF neurotoxicity via antioxidative effects mediated by the Nrf2 pathway
Bowen Yan, Geng Lu, Rong Wang, et al.
Frontiers of Chemical Science and Engineering (2023) Vol. 17, Iss. 7, pp. 976-989
Closed Access | Times Cited: 7
Cannabinoids and healthy ageing: the potential for extending healthspan and lifespan in preclinical models with an emphasis on Caenorhabditis elegans
Zhizhen Wang, Jonathon C. Arnold
GeroScience (2024) Vol. 46, Iss. 6, pp. 5643-5661
Closed Access | Times Cited: 2
Liquid-Liquid Phase Separation Promotes Protein Aggregation and Its Implications in Ferroptosis in Parkinson’s Disease Dementia
Mengzhu Li, Yaohua Fan, Qinglian Li, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-13
Open Access | Times Cited: 11
Co-Dispersion Delivery Systems with Solubilizing Carriers Improving the Solubility and Permeability of Cannabinoids (Cannabidiol, Cannabidiolic Acid, and Cannabichromene) from Cannabis sativa (Henola Variety) Inflorescences
Anna Stasiłowicz-Krzemień, Piotr Szulc, Judyta Cielecka‐Piontek
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2280-2280
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top